Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 583 (LINC00583) is a long intergenic non-coding RNA gene, meaning it is transcribed into a non-protein coding RNA molecule longer than 200 nucleotides and located in a genomic region that does not overlap with protein-coding genes[5][1]. LINC00583 belongs to the class of lincRNAs, which are distinguished from other non-coding RNAs by their length and genomic location. LincRNAs are recognized for their roles in chromatin remodeling, transcriptional regulation, and regulation of neighboring gene expression, often in a tissue- or context-specific manner, but only a small subset of annotated lincRNAs have been functionally characterized in detail[3][7]. There is currently no evidence that LINC00583 is a direct therapeutic target (such as a receptor, enzyme, transporter, etc.), nor are there established interacting drugs, biomarker roles, or documented safety concerns associated specifically with LINC00583[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 583 (LINC00583).